Page last updated: 2024-08-25

rosiglitazone and MPTP Neurotoxicity Syndrome

rosiglitazone has been researched along with MPTP Neurotoxicity Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carta, AR; Lecca, D; Mulas, G; Pisanu, A; Simbula, G; Spiga, S; Wardas, J1
Caboni, P; Carboni, E; Carta, AR; Frau, L; Garau, A; Ibba, M; Schintu, N1

Other Studies

2 other study(ies) available for rosiglitazone and MPTP Neurotoxicity Syndrome

ArticleYear
Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease.
    Neurobiology of disease, 2014, Volume: 71

    Topics: Animals; Cell Count; Cell Polarity; Cytokines; Disease Models, Animal; Gene Expression Regulation; Mice; Microglia; MPTP Poisoning; Nerve Degeneration; Neuroprotective Agents; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Tyrosine 3-Monooxygenase

2014
PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson's disease.
    The European journal of neuroscience, 2009, Volume: 29, Issue:5

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Catalepsy; CD11b Antigen; Chromatography, High Pressure Liquid; Chronic Disease; Disease Models, Animal; Dopamine; Drug Interactions; Dynorphins; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Globus Pallidus; Locomotion; Male; Mice; Mice, Inbred C57BL; Motor Activity; MPTP Poisoning; PPAR gamma; Psychomotor Performance; RNA, Messenger; Rosiglitazone; Smell; Tandem Mass Spectrometry; Thiazolidinediones; Tyrosine 3-Monooxygenase

2009